BREAKING: The FDA approved #roflumilast cream 0.15% for atopic dermatitis (in those aged 6 years +). View more here: hcplive.com/view/roflumila…

Need a breakdown of CATALYST and hypercortisolism in #Type2Diabetes? Check out the latest #DiabetesDialogue with @Natalie_Bellini and Diana Isaacs, PharmD, BC-ADM, CDCES! hcplive.com/view/diabetes-…

Tirzepatide proves benefit in HF. Story to come on HCPLive:

🚨 Breaking News!🚨 Eli Lilly and Company's tirzepatide showed a 38% reduction in heart failure outcomes and improved symptoms in adults with HFpEF and obesity, according to topline data from the phase 3 SUMMIT trial. Learn more: lnkd.in/ej2spXfh #Obesity #HeartFailure

BREAKING: Iptacopan (Fabhalta) has received accelerated approval for reducing proteinuria in adults with primary IgAN, according to a release from @novartis. Learn more: hcplive.com/view/iptacopan… #IgANephropathy #Nephrology

Had another opportunity to interview Raj Chovatiya, MD PhD on his team's findings on the prevalence of #SeborrheicDermatitis. Dr. Chovatiya's interviews with HCPLive are always a highlight of our #dermatology coverage. Informative as always! Check it out here: hcplive.com/view/discussin…

This just in: the #FDA approved the nasal spray 'neffy' for the treatment of anaphylaxis. It is the first non-injectable treatment for severe allergic reactions, a viable alternative to the EpiPen. This is big! 😮 Our summary of the announcement: hcplive.com/view/fda-appro…

New #DiabetesDialogue! Diana Isaacs, PharmD, BC-ADM, CDCES and Natalie Bellini are joined by Muthu Vaduganathan to discuss recent developments in #HFpEF, namely topline data announcements from the SUMMIT and FINEARTS-HF trials. hcplive.com/view/diabetes-… #HeartFailure

New #Lungcast! For Back to School, the American Lung Association spoke with Juanita Mora, MD and Christy Sadreameli on a number of pediatric respiratory health topics—#RSV risk, vaping, and the dreaded #Asthma Peak Week. Watch / listen to the full episode here: hcplive.com/view/back-to-s…

Matt Weir & I offer an obituary of our affable colleage George Bakris ahajournals.org/doi/abs/10.116… "With a diagnosis of cancer 4 years ago, pain was inevitable. But how to respond to this crisis was a choice. Dr Bakris inspired us by publishing >200 papers while battling his disease."

Just boarded my flight to #ESCCongress. Got seated next to a very good boy.

“The risks of omission in #heartfailure management - speeding up the implementation of guideline-directed heart failure therapy” Stellar panel of experts - Carys Barton 💙🫀#25in25 #Freedomfromfailure Muthu Vaduganathan Steve Greene Gianluigi Savarese

Witnessed an Erling Haaland hat trick.

Lovely final slide of the FINEHEART presentation from Muthu Vaduganathan dedicated to the late Professor George Bakris #ESCCongress

Feels like all the 35k attendees are in the main auditorium. #ESCCongress

No #cardiology meeting is complete without a recording of #DontMissABeat! In this episode, Muthu Vaduganathan plays the role of host and special guest as he discusses the meeting’s hottest topic, FINEARTS-HF, w/ Steve Greene. Episode out tomorrow! #ESCCongress #HeartFailure